The frequency and VEN-analysis of pharmacotherapy in children with ARVI in the healthcare institution of the Poltava region

Abstract

Acute respiratory viral infections (ARVI) are diseases that have important medico-social importance since they are associated with a wide distribution among the population, the risk of complications, reduced quality of life of patients, and high total cost of treatment. Aim. To assess the quality of pharmacotherapy: the frequency of prescribing drugs for children with ARVI in the healthcare institution of the Poltava region and the correspondence of drug prescriptions to clinical protocols for providing medical care and the State Formulary of Medicines of Ukraine (SFMU). Materials and methods. The quality assessment of pharmacotherapy of children with ARVI was performed using auxiliary clinical and economic methods – the frequency and formal VEN-analyses. Results. The main directions of pharmacotherapy of children with ARVI in one of the healthcare institution of the Poltava region correspond to the unified clinical protocol of the primary care for adults and children with ARVI and clinical protocols for pharmacotherapy of concomitant diseases. Using the formal VEN-analysis it has been determined that the majority of INN drugs prescribed are recommended by clinical protocols for pharmacotherapy of the main (ARVI) and associated diseases registered in patients, and are available in the SFMU (87.50 and 54.69 %, respectively). Conclusions. The formal VEN analysis has shown that the ARVI pharmacotherapy correction is needed in the healthcare institution of the Poltava region studied since a significant part of the INN drugs prescribed is absent in the SFMU (45.31 %) and in clinical protocols for the primary pharmacotherapy (ARVI) and associated diseases (17.19 %). In both medical and technological documents there are no 12.50 % of INNs prescribed. For them 11.74 % of funds (4808.81 UAH) were spent by parents of sick children; they were prescribed 8.74 % times (38 prescriptions) of the total number of prescriptions – 431.

Authors and Affiliations

O. V. Tkachоva, O. Ya. Mishchenko, T. I. Sheptak

Keywords

Related Articles

The study of the sedative effect of “sedosten” extract

Various socio-psychological and biological factors lead to manifestations of the central nervous system disorders. The use of drugs of chemical origin for correction of the CNS disorders increases the risk of side effect...

The serum levels of cytokines in thyroid heart failure patients

In recent years, the system of cytokines has a significant role in forming and progressing chronic heart failure of various etiologies (ischemic, inflammatory, infectious and allergic, etc.). Aim. To study the activity o...

Вивчення противиразкової дії ліофілізованого екстракту трави хамерію вузьколистого на моделі етанол-преднізолонового ураження шлунка у щурів

Терапія виразкової хвороби включає схеми використання ряду лікарських засобів, більшість з яких є синтетичними з великою кількістю побічних ефектів і протипоказань. Тому пошук альтернативних засобів рослинного походження...

The frequency and VEN-analysis of pharmacotherapy in children with ARVI in the healthcare institution of the Poltava region

Acute respiratory viral infections (ARVI) are diseases that have important medico-social importance since they are associated with a wide distribution among the population, the risk of complications, reduced quality of l...

The study of the emotional and behavioral response in rats after introduction of the neogalenical phytocomplex from Ledum palustre shoots

While studying new medicinal products their effect on the central nervous system should be researched, namely the hypnotic and anxiolytic action of drugs should be determined. The results of the studies are necessary for...

Download PDF file
  • EP ID EP657952
  • DOI 10.24959/cphj.19.1495
  • Views 87
  • Downloads 0

How To Cite

O. V. Tkachоva, O. Ya. Mishchenko, T. I. Sheptak (2019). The frequency and VEN-analysis of pharmacotherapy in children with ARVI in the healthcare institution of the Poltava region. Клінічна фармація; Клиническая фармация, 23(2), 48-53. https://www.europub.co.uk/articles/-A-657952